A Phase II investigator-led trial investigating AstraZeneca’s Fasenra (benralizumab) treating eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD) has ...

The China National Medical Products Association (NMPA) has approved AstraZeneca's Fasenra (benralizumab) as a maintenance ...

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

Fasenra is approved as an add-on maintenance treatment for severe, eosinophilic asthma in the US, EU, Japan and other countries. Mene Pangalos, AZ's president of BioPharmaceuticals R&D ...

AZ said Fasenra (benralizumab) has been approved as an add-on maintenance treatment in adults with severe eosinophilic asthma, inadequately controlled on standard inhaled corticosteroid and long ...

The association between early childhood serum 25-hydroxyvitamin D (25(OH)D) and eosinophilic asthma remains unclear. We ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD), according to a study published online Nov. 27 in The ...

Interestingly, around 50% of patients with asthma also have a high number of circulating eosinophils. Patients with eosinophilic asthma tend to have more severe disease, and more frequent asthma ...

LONDON: AstraZeneca's Fasenra, an injectable treatment for ... for a severe form of the breathing disorder called eosinophilic asthma that targets a type of white blood cell associated with ...

Read on to know more about this. DCGI approves AstraZeneca's injection 'Fasenra' for treatment of severe eosinophilic asthma Eosinophilic asthma (EA) is a type of asthma that is characterised by ...

Administering the drug via injection during eosinophilic exacerbations reduced the need for further treatment by 30% compared to traditional steroid tablets like prednisolone. “This could be a ...

which are a key cause of the eosinophilic subtype of asthma. Studies have also shown that patients on Fasenra could reduce their oral steroid intake significantly, thereby reducing the potential ...